The Effect of Desflurane on Postopertative Cognitive Dysfunction

NCT ID: NCT04541823

Last Updated: 2021-08-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-01

Study Completion Date

2023-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the effect of desflurane on postoperative cognitive dysfunction

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Postoperative cognitive dysfunction is a common complication during postoperative period,especially in elderly patients. It is characterized by cognitive decline, inattention and abnormal mental status following surgery. The presence of postoperative cognitive dysfunction is independently associated with poor recovery, increased hospital length of stay and increased mortality.

Desflurane is a widely used volatile anesthetic, associated with shorter emergence times than other volatile anesthetics. This study aims to access the effect of desflurane in preventing postoperative cognitive dysfunction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Cognitive Dysfunction Postoperative Delirium

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Desflurane

Patients allocated to this arm will receive desflurane during the maintenance of anesthesia.

Group Type EXPERIMENTAL

Desflurane

Intervention Type DRUG

Investigators administrated desflurane with target of BIS 40-60 during the maintenance of anesthesia

Propofol

Patients allocated to this arm will receive propofol during the maintenance of anesthesia

Group Type PLACEBO_COMPARATOR

Propofol

Intervention Type DRUG

Investigators administrated propofol with target of BIS 40-60 during the maintenance of anesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Desflurane

Investigators administrated desflurane with target of BIS 40-60 during the maintenance of anesthesia

Intervention Type DRUG

Propofol

Investigators administrated propofol with target of BIS 40-60 during the maintenance of anesthesia

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1\. Written consent given
* 2\. Scheduled to undergo elective non-cardiac surgeries under general anesthesia
* 3\. ASA Physical Score I-III

Exclusion Criteria

* 1\. Patients with a history of neurological disease, such as Alzheimer disease.
* 2\. Patients with a history of psychiatric disease
* 3\. Patients with a medication history of antipsychotic drugs.
* 4\. Unable to complete neuropsychological testing including patients with severe visual or hearing impairment.
* 5\. Patients with preoperative delirium.
* 6\. Patients who have severe adverse events, such as cardiac arrest.
* 7\. Patients who preoperative MMSE score are below 20;
* 8\. Patients who undergo second operation in a short period.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beijing Chao Yang Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Anshi Wu

Head of Anesthesiology

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beijing Chaoyang Hospital, Capital Medical University

Beijing, Beijing Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Anshi Wu, MD

Role: primary

+8685231330

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

00375928

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.